Françoise Rothé

3PUBLICATIONS
44CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 16, 2025
Unraveling the Tumor Microenvironment and PD-L1 Expression across Tissue Types in High-Grade Serous Ovarian Cancer in the NeoPembrOV/GINECO Phase II Randomized Trial.

Laetitia Collet, Maude Ardin, David Venet

|Oct 29, 2024
Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: An Analysis of the ZEPHIR Clinical Trial.

Mattia Rediti, Danai Fimereli, Magdalena Mileva

|Sep 21, 2023
Differential Benefit of Metronomic Chemotherapy Among Triple-Negative Breast Cancer Subtypes Treated in the IBCSG Trial 22-00.

Andrea Joaquin Garcia, Mattia Rediti, David Venet

Pageof 1

Frequent Collaborators

3 joint publications

David Venet

3 joint publications

Christos Sotiriou

2 joint publications

Mattia Rediti

2 joint publications

Samira Majjaj